1.40
price up icon3.70%   0.05
after-market アフターアワーズ: 1.40
loading
前日終値:
$1.35
開ける:
$1.37
24時間の取引高:
376.63K
Relative Volume:
2.95
時価総額:
$51.20M
収益:
-
当期純損益:
$-9.16M
株価収益率:
-2.4561
EPS:
-0.57
ネットキャッシュフロー:
$-8.75M
1週間 パフォーマンス:
+17.65%
1か月 パフォーマンス:
+44.36%
6か月 パフォーマンス:
+10.24%
1年 パフォーマンス:
+19.66%
1日の値動き範囲:
Value
$1.31
$1.40
1週間の範囲:
Value
$1.20
$1.40
52週間の値動き範囲:
Value
$0.75
$1.6899

Renovorx Inc Stock (RNXT) Company Profile

Name
名前
Renovorx Inc
Name
セクター
Healthcare (1170)
Name
電話
408-800-2649
Name
住所
2570 W. EL CAMINO REAL, STE. 320,, MOUNTAIN VIEW
Name
職員
10
Name
Twitter
Name
次回の収益日
2024-08-15
Name
最新のSEC提出書
Name
RNXT's Discussions on Twitter

RNXT を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Biotechnology icon
RNXT
Renovorx Inc
1.40 43.52M 0 -9.16M -8.75M -0.57
Biotechnology icon
ONC
Beone Medicines Ltd Adr
245.58 26.10B 3.81B -644.79M -669.77M -6.24
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
442.05 111.96B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
AKTX
Akari Therapeutics Plc Adr
1.35 42.96M 0 0 0 0.00
Biotechnology icon
VRNA
Verona Pharma Plc Adr
81.20 6.39B 0 -153.72M -103.81M -2.00
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
490.28 63.52B 14.09B 4.50B 2.96B 39.28

Renovorx Inc (RNXT) 最新ニュース

pulisher
May 29, 2025

New U.S. Patent Issued to RenovoRx for Drug Therapy Platform - Medical Product Outsourcing

May 29, 2025
pulisher
May 25, 2025

RenovoRx (NASDAQ:RNXT) Is Revolutionizing Cancer Treatment - simplywall.st

May 25, 2025
pulisher
May 22, 2025

Q2 Earnings Forecast for RenovoRx Issued By HC Wainwright - Defense World

May 22, 2025
pulisher
May 21, 2025

RenovoRx, Inc. (RNXT) Reports Q1 Loss, Lags Revenue Estimates - MSN

May 21, 2025
pulisher
May 20, 2025

RenovoRx (NASDAQ:RNXT) Receives “Buy” Rating from HC Wainwright - Defense World

May 20, 2025
pulisher
May 20, 2025

RenovoRx Buy Rating: Promising RenovoCath Adoption and TIGeR-PaC Study Progress Drive Positive Outlook - TipRanks

May 20, 2025
pulisher
May 19, 2025

RenovoRx (RNXT): HC Wainwright Reiterates Buy Rating with $3.00 Target | RNXT Stock News - GuruFocus

May 19, 2025
pulisher
May 18, 2025

RenovoRx, Inc. (NASDAQ:RNXT) Q1 2025 Earnings Call Transcript - MSN

May 18, 2025
pulisher
May 17, 2025

RenovoRx’s Innovative Drug Delivery and Promising Clinical Trials Earn a Buy Rating - TipRanks

May 17, 2025
pulisher
May 16, 2025

RenovoRx Earnings Call: Positive Outlook Amid Growth - TipRanks

May 16, 2025
pulisher
May 16, 2025

RenovoRx Inc (RNXT) Q1 2025 Earnings: EPS of -$0.08 Beats Estima - GuruFocus

May 16, 2025
pulisher
May 16, 2025

RenovoRx earnings beat, revenue fell short of estimates - Investing.com Australia

May 16, 2025
pulisher
May 16, 2025

Earnings call transcript: RenovoRx Q1 2025 revenue exceeds expectations By Investing.com - Investing.com Nigeria

May 16, 2025
pulisher
May 16, 2025

RenovoRx Reports Promising Q1 2025 Financial Results - TipRanks

May 16, 2025
pulisher
May 15, 2025

Earnings call transcript: RenovoRx Q1 2025 revenue exceeds expectations - Investing.com

May 15, 2025
pulisher
May 15, 2025

RenovoRx earnings beat, revenue fell short of estimates By Investing.com - Investing.com India

May 15, 2025
pulisher
May 15, 2025

RenovoRx Reports First Quarter 2025 Financial Results and Business Highlights - BioSpace

May 15, 2025
pulisher
May 15, 2025

RenovoRx Q1 2025 Earnings Call Transcript - MarketBeat

May 15, 2025
pulisher
May 15, 2025

RenovoRx reports Q1 EPS (8c), consensus (8c) - TipRanks

May 15, 2025
pulisher
May 15, 2025

RenovoRx (RNXT) Reports Strong Q1 Revenue Surpassing Expectations | RNXT Stock News - GuruFocus

May 15, 2025
pulisher
May 15, 2025

RenovoRx Reports Strong Q1 2025 Financial Results - TipRanks

May 15, 2025
pulisher
May 14, 2025

RenovoRx to Participate in Fireside Chat at A.G.P. Virtual Healthcare Company Showcase on May 21st - BioSpace

May 14, 2025
pulisher
May 08, 2025

RenovoRx Expands RenovoCath Production to Meet an Increasing Demand - Zenopa

May 08, 2025
pulisher
May 08, 2025

Renaissance Technologies LLC Makes New Investment in RenovoRx, Inc. (NASDAQ:RNXT) - Defense World

May 08, 2025
pulisher
May 06, 2025

RenovoRx Ramps Up U.S. Production of RenovoCath Devices - Medical Product Outsourcing

May 06, 2025
pulisher
May 06, 2025

U.S. Patent Office Issues New Patent to RenovoRx for Novel Trans-Arterial Micro-Profusion (TAMP™) Therapy Platform - Business Wire

May 06, 2025
pulisher
May 02, 2025

RenovoRx (RNXT) Projected to Post Earnings on Friday - Defense World

May 02, 2025
pulisher
May 01, 2025

RenovoRx to Host First Quarter 2025 Financial Results Conference Call on May 15th at 4:30 p.m. ET - BioSpace

May 01, 2025
pulisher
Apr 30, 2025

CM24 Combo With Biomarker Targeting Improves Survival in Pancreatic Cancer - Curetoday

Apr 30, 2025
pulisher
Apr 30, 2025

Ascendiant Capital Markets Forecasts Strong Price Appreciation for RenovoRx (NASDAQ:RNXT) Stock - The AM Reporter

Apr 30, 2025
pulisher
Apr 29, 2025

RenovoRx (RNXT) Advances Phase III Trial for Pancreatic Cancer T - GuruFocus

Apr 29, 2025
pulisher
Apr 29, 2025

RenovoRx (RNXT) Advances Phase III Trial for Pancreatic Cancer Treatment | RNXT Stock News - GuruFocus

Apr 29, 2025
pulisher
Apr 29, 2025

Johns Hopkins Medicine Initiates Patient Enrollment For Renovorx'S Ongoing Phase III Tiger-Pac Clinical Trial - marketscreener.com

Apr 29, 2025
pulisher
Apr 29, 2025

Johns Hopkins Medicine Initiates Patient Enrollment for RenovoRx’s Ongoing Phase III TIGeR-PaC Clinical Trial - Business Wire

Apr 29, 2025
pulisher
Apr 29, 2025

RenovoRx (NASDAQ:RNXT) Price Target Raised to $11.00 at Ascendiant Capital Markets - Defense World

Apr 29, 2025
pulisher
Apr 27, 2025

RenovoRx Reports Initial Revenue and Clinical Trial Progress - MSN

Apr 27, 2025
pulisher
Apr 17, 2025

RenovoRx CMO Makes Bold Stock Purchase! - TipRanks

Apr 17, 2025
pulisher
Apr 17, 2025

RenovoRx chief medical officer Agah Ramtin buys $13,500 in common stock - Investing.com Australia

Apr 17, 2025
pulisher
Apr 17, 2025

RenovoRx chief medical officer Agah Ramtin buys $13,500 in stock - Investing.com Australia

Apr 17, 2025
pulisher
Apr 17, 2025

RenovoRx chief medical officer Agah Ramtin buys $13,500 in stock By Investing.com - Investing.com Canada

Apr 17, 2025
pulisher
Apr 17, 2025

RenovoRx chief medical officer Agah Ramtin buys $13,500 in common stock By Investing.com - Investing.com South Africa

Apr 17, 2025
pulisher
Apr 17, 2025

Jersey Shore debuts N.J.’s first TAMP cancer therapy - ROI-NJ

Apr 17, 2025
pulisher
Apr 16, 2025

RenovoRx ramps up production of FDA-cleared RenovoCath By Investing.com - Investing.com India

Apr 16, 2025
pulisher
Apr 16, 2025

New Jersey Patients Receiving First-of-Its-Kind Catheter Based Pancreatic Cancer Treatment | Newswise - Newswise

Apr 16, 2025
pulisher
Apr 16, 2025

RenovoRx CEO Shaun Bagai acquires $6,821 in common stock - Investing.com Australia

Apr 16, 2025
pulisher
Apr 16, 2025

RenovoRx CEO Shaun Bagai acquires $6,821 in common stock By Investing.com - Investing.com Canada

Apr 16, 2025
pulisher
Apr 16, 2025

RenovoRx Increases U.S. Production of RenovoCath® Devices to Meet Growing Demand from Oncology Community - BioSpace

Apr 16, 2025
pulisher
Apr 16, 2025

RenovoRx ramps up production of FDA-cleared RenovoCath - Investing.com

Apr 16, 2025
pulisher
Apr 16, 2025

Renovorx Increases U.S. Production Of Renovocath Devices To Meet Growing Demand From Oncology Community - marketscreener.com

Apr 16, 2025
pulisher
Apr 16, 2025

Medical Device Maker RenovoRx Eyes $400M Market With Surging RenovoCath Demand - Stock Titan

Apr 16, 2025

Renovorx Inc (RNXT) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$1.08
price up icon 1.89%
$30.14
price down icon 3.74%
$573.26
price down icon 1.32%
$304.56
price up icon 3.98%
$4.50
price down icon 3.02%
$490.28
price down icon 19.01%
大文字化:     |  ボリューム (24 時間):